diphenyleneiodonium has been researched along with Pulmonary Hypertension in 1 studies
diphenyleneiodonium: structure in first source; NADPH oxidase inhibitor
dibenziodolium : An organic cation that is fluorene in which the methylene group is replaced by a positively charged iodine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peng, JJ | 1 |
| Liu, B | 1 |
| Xu, JY | 1 |
| Peng, J | 1 |
| Luo, XJ | 1 |
1 review available for diphenyleneiodonium and Pulmonary Hypertension
| Article | Year |
|---|---|
NADPH oxidase: its potential role in promotion of pulmonary arterial hypertension.
Topics: Acetophenones; Animals; Humans; Hypertension, Pulmonary; NADPH Oxidases; Onium Compounds; Resveratro | 2017 |